Willow Biosciences Inc.
CANSF
$0.02
-$0.0035-14.89%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -220.90K | -641.50K | -913.50K | -1.23M | -1.75M |
| Total Depreciation and Amortization | 9.80K | 520.10K | 230.20K | 258.00K | 261.10K |
| Total Amortization of Deferred Charges | -- | 4.30K | -- | -- | -- |
| Total Other Non-Cash Items | 47.40K | -20.70K | 104.80K | 106.00K | 48.20K |
| Change in Net Operating Assets | 137.30K | 162.20K | -87.20K | 333.20K | 142.40K |
| Cash from Operations | -26.50K | -237.90K | -665.70K | -535.70K | -1.30M |
| Capital Expenditure | -- | 0.00 | -14.70K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 0.00 | -- | -- | 100.10K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 37.10K | -65.30K | -- | -- |
| Cash from Investing | -- | 37.10K | -79.90K | -- | 100.10K |
| Total Debt Issued | -- | -1.91M | 1.09M | 547.00K | -- |
| Total Debt Repaid | -265.00K | -264.00K | -198.00K | -200.00K | -198.00K |
| Issuance of Common Stock | -- | 0.00 | 2.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 285.00K | 1.90M | -253.00K | -1.00K | 269.00K |
| Cash from Financing | 13.90K | -196.50K | 472.20K | 252.90K | 52.70K |
| Foreign Exchange rate Adjustments | -2.10K | 21.40K | -3.70K | 2.90K | 13.40K |
| Miscellaneous Cash Flow Adjustments | -104.50K | -- | 401.10K | -399.70K | -- |
| Net Change in Cash | -119.10K | -375.80K | 123.90K | -679.60K | -1.13M |